<DOC>
	<DOCNO>NCT00818610</DOCNO>
	<brief_summary>The purpose study determine whether monotherapy Beta-Lactam inferior association Beta-Lactam macrolide treat adult patient community-acquired pneumonia .</brief_summary>
	<brief_title>Monotherapy Versus Bitherapy Non-severe Hospitalized Community-acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Cefuroxime</mesh_term>
	<mesh_term>Cefuroxime axetil</mesh_term>
	<criteria>Age &gt; =18 year New infiltrate chest Xray , unexplained another disease process Presence least two follow finding suggestive pneumonia : fever hypothermia , new increase cough , sputum production , pleuritic chest pain , tachypnea , dyspnea focal sign chest examination Need hospitalization define emergency physician charge patient Allergy one study drug Pregnancy Severe immunosuppression Recent ( &lt; 14 ) hospitalization , currently hospitalize since &gt; 48 hour Residency nursing home Previous use 24 hour antibiotic Severe communityacquired pneumonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Community-acquired infection</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Clinical Stability</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Combination therapy</keyword>
	<keyword>Atypical bacteria</keyword>
</DOC>